Search

Pharmacological propertiesPharmacodynamics. Rosuvastatin is a selective competitive inhibitor of hmg-coa reductase, an enzyme that converts hmg-coa into mevalonate, a precursor of chs. the main site of action of rosuvastatin is the liver, where the synthesis of xc and LDL catabolism is carried out.R..

Pharmacological propertiesPharmacodynamics. Rosuvastatin is a selective competitive inhibitor of hmg-coa reductase, an enzyme that converts hmg-coa into mevalonate, a precursor of chs. the main site of action of rosuvastatin is the liver, where the synthesis of xc and LDL catabolism is carried out.R..